Patent US5075341A successfully refreshed from Google Patents.
US5075341A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment for cocaine abuse
Assignee: McLean Hospital
•
Filing: 1989-12-01
•
Granted: 1991-12-24
•
Expires: 2009-12-01
Abstract
Abstract Mixed opiate agonist/antagonists, particularly buprenorphine, is provided for the treatment of cocaine dependence and concurrent cocaine and opiate abuse and dependence.
Inventors
- 👤 Jack H. Mendelson
- 👤 Nancy K. Mello
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 12:13
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/485
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
25 words
A method for treating cocaine abuse and dependence in drug addicts comprising: administering to said addict an effective amount of buprenorphine to suppress drug abuse.
Claim 2
Independent Claim
25 words
A method for treating cocaine abuse and dependence in drug addicts comprising: administering to said addict an effective amount of buprenorphine to suppress drug abuse.
Claim 3
Dependent Claim
19 words
A method according to claim 1, wherein said effective amount comprises about 0.02 to about 1.50 mg/kg body weight/day.
Claim 4
Dependent Claim
19 words
A method according to claim 2, wherein said effective amount comprises about 0.05 to about 0.90 mg/kg body weight/day.
Claim 5
Dependent Claim
14 words
A method according to claim 1, wherein said administering comprises sublingual and subcutaneous administration.
Claim 6
Dependent Claim
12 words
A method according to claim 4, wherein said administering comprises subcutaneous administration.
Claim 7
Independent Claim
31 words
A method for using buprenorphine for the treatment of drug abuse and dependence comprising: administering to humans abusing or addicted to cocaine an effective amount of buprenorphine to suppress drug abuse.
Claim 8
Independent Claim
31 words
A method for using buprenorphine for the treatment of drug abuse and dependence comprising: administering to humans abusing or addicted to cocaine an effective amount of buprenorphine to suppress drug abuse.
Claim 9
Dependent Claim
19 words
A method according to claim 6, wherein said effective amount comprises about 0.02 to about 1.50 mg/kg body weight/day.
Claim 10
Dependent Claim
19 words
A method according to claim 6, wherein said effective amount comprises about 0.05 to about 0.90 mg/kg body weight/day.
Claim 11
Dependent Claim
14 words
A method according to claim 6, wherein said administering comprises sublingual and subcutaneous administration.
Claim 12
Dependent Claim
12 words
A method according to claim 9, wherein said administering comprises subcutaneous administration.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-12-23 | 1995-06-24 | 1995-12-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-12-23 | 1999-06-24 | 1999-12-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-12-23 | 2003-06-24 | 2003-12-24 | $7700.00 | Window Closed / Lapsed |